Open Evidence’s Post

💊 Great programme today, on the occasion of the European #AntibioticAwareness Day #EAAD, at the "Symposium zum 17. Europäischen Antibiotikatag" organized by #BMSGPK with talks from the human, veterinary and environmental sector in line with the #OneHealth approach. 🌍 First talk given by D. Monnet from the European Centre for Disease Prevention and Control (ECDC) on "Antibiotic resistance trends and emerging resistance in the EU/EEA: most recent data from ECDC" giving interesting insights how the EU and the individual member states including Austria are performing towards reaching their targets combating #AMR as outlined in the Council Recommendation of 2023. 👉 We are generally on a good path, with #carbapenem resistant Enterobacterales being a concerning exception. 👉 We can make a change by implementing actions like improved #handhygiene, #antimicrobial stewardship, public awareness, ... 👉 Many actions combined will make a difference! Let's tackle it together step by step! 👉 Investment costs for actions combating #AMR are also predicted to pay off financially Looking forward to many more exciting presentations!

Insights from Pakistan's National Action Plan (NAP) on Antimicrobial Resistance (AMR). This plan is pivotal in combating the rising global challenge of AMR, which threatens both human and animal health. 📌 Best Part of the Policy: The holistic "One Health" approach, integrating human, animal, and environmental health, is a standout feature. It ensures a comprehensive strategy to tackle AMR from all angles. 📌 Areas for Improvement: 🔸Setting specific timelines and measurable targets. 🔸Detailed resource allocation and funding mechanisms. 🔸Enhanced public and private sector engagement. 🔸Robust continuous monitoring and evaluation systems. 📌 Implementation Effectiveness: 🔸Awareness and Behavioral Change: Initial success in raising awareness, but efforts need to be scaled up. 🔸Regulatory Updates: Progress in updating regulations, but enforcement is inconsistent. 🔸Surveillance Systems: Progress in establishing integrated AMR surveillance systems, though full integration is pending. 📌 Challenges in Implementation: 🔸Limited financial and technical resources. 🔸Need for stronger institutional capacities. 🔸Inconsistent political will and governance challenges. 🔸Coordination challenges across sectors. 🔸Insufficient public awareness and engagement. The NAP is a significant step towards a sustainable and equitable health future. By addressing these gaps, we can ensure effective action against AMR, safeguarding health for generations to come.🌍💊🎉🦠🇵🇰 Pakistan NAP on AMR: https://lnkd.in/erq_rA6X #AMR #OneHealth #PakistanNationalActionPlan #PublicHealth #Policy #Awareness #Innovation #Healthcare #Environment #AnimalHealth

Today we had an incredibly insightful panel at the World Anti-Microbial Resistance Congress: "A One Health Approach: Wastewater Surveillance for AMR". The discussion highlighted the critical role of wastewater surveillance as a key tool in monitoring antimicrobial resistance (AMR), enabling a more integrated and effective response to this global challenge. The speakers brought valuable perspectives on how the One Health approach can tackle AMR: Alexandra Mendley – Associate Director for Antimicrobial Resistance, Centers for Disease Control and Prevention (Centers for Disease Control and Prevention), discussed surveillance initiatives in the U.S. Francesca Chiara – Chair, The AMR Narrative, emphasized the importance of clear communication on the impacts of AMR. Windi Muziasari – CEO of Resistomap, showcased advances in wastewater AMR monitoring technologies. Nichole Brinkman – US Environmental Protection Agency (EPA), highlighted the role of the EPA in environmental surveillance as part of the One Health strategy. It was an enriching discussion on how the integration of public, environmental, and animal health can help address the AMR crisis. #AMR #OneHealth #WorldAMRCongress #antimicrobialresistance #wastewatersurveillance #innovation #CDC #EPA #Resistomap

In preparation for the UN high level meeting on AMR #AMRHLM that will take place in September this year, the AMR global leaders group #AMRGLG drafted recommendations for the member states to consider in advance. They are meant to support the process, facilitate specific commitments, and maximize the outcome of this critical event with the goal to "move the world from rhetoric to specific #commitments and action".     The initial action plan by the GLG left two gaping blanks regarding financing, measurability of the outcome, and accountability. The new report now offers suggestions for exactly these pain points: - Mobilize additional stakeholders and leverage existing financing instruments. - Establish an independent monitoring board and national #accountability coordinators under the leadership of the Quadripartite Joint Secretariat on AMR #QJSAMR. - Strengthen antimicrobial use and resistance surveillance, prevent environmental contamination, and reduce the need for antimicrobials by boosting #prevention and control.   As global targets by 2030 the group suggests: ·       To reduce death caused by AMR by 10%. ·       To reduce the use of RESERVE and WATCH antibiotics, so that 80% of human antibiotic consumption comprises ACCESS group antibiotics. ·       To reduce general agri-food antimicrobial use by 30-50% and eliminate the use of human important drugs in non-veterinary agriculture.   To back up this report and to help mobilize financial resources the #QJSAMR built the economic case comparing the cost of implementing a defined package of #interventions combating #AMR to the cost of inaction. According to this report the global additional #healthcarecost for AMR would be $ 412 billion a year and another $ 443 billion per year in lost workforce productivity, based on average national wage. This would add up to 💸 $ 25,650 billion in 30 years. In contrast the total investment required for the intervention package across the regions was estimated at about US$ 1,420.7 billion for the 30-year period. This would, besides the development of new antimicrobials, include incentives to do so, implementing WASH and environmental hygiene, stewardship programs, education and diagnostics. The undeniable critical gap of #diagnostics that are essential and the basis for appropriate clinical care, antimicrobial #stewardship, and all surveillance efforts has been acknowledged  - let’s hope diagnostics will get the airtime it deserves in September! https://lnkd.in/ecDh5wpq https://lnkd.in/eA7TwdJP

Centrient is proud to support the AMR Industry Alliance's Chair James Anderson, who spoke at the United Nations High-Level Meeting on AMR, emphasizing the urgent need for action. James highlighted key priorities, including the adoption of responsible manufacturing standards like AMRIA's Antibiotic Manufacturing Standard, transforming the market with new incentives, ensuring equitable access, and promoting the responsible use of antibiotics. As a member of the AMR Industry Alliance, Centrient remains committed to raising awareness and driving progress in the fight against antimicrobial resistance. We will continue advocating for responsible antibiotic use and sustainable practices to tackle AMR and safeguard human and environmental health. Together, we can make a lasting impact. Watch the full panel on AMR here: https://lnkd.in/dhS4Nxgd #AMR #ResponsibleManufacturing #UNGA79

Are you interested in antimicrobial consumption in humans and animals and AMR issues in Europe? You can have a look at the 4th Joint inter-agency report published by EFSA, ECDC and EMA. #AMR #AntimicrobialConsumption #EFSA #EMA #ECDC 👉👉ow.ly/XRVM50QLMeC

AMRIA Chair James Anderson addressed the United Nations today during the High-level Meeting on #AMR as part of the panel "Addressing human health, animal health and welfare, agrifood systems, and protecting the environment to tackle antimicrobial resistance, through integrated surveillance, capacity-building, sustainable resources, financing, and investment." James addressed the need for action, particularly the adoption of responsible manufacturing standards (such as AMRIA's Antibiotic Manufacturing Standard and BSI's certification program), the transformation of the market with new incentives, actionable steps to ensure equitable access, and improving appropriate use of antimicrobials. Watch the full panel on UN WebTV here: https://lnkd.in/dhS4Nxgd

UPP is pleased to sign the Investor Action on Antimicrobial Resistance (IAAMR)’s Public Investor Statement, which calls for global action to combat #DrugResistance. Antimicrobial resistance (#AMR) is considered one of the top global threats to human and animal health and is predicted to cause a 3.8% decrease in global GDP by 2050. The Statement urges world leaders and policymakers to intensify efforts, coordinate action, and reaffirm commitments to tackle AMR. Read the statement here ➡ https://lnkd.in/duwcSVgp FAIRR Initiative | UK Department of Health and Social Care | Access to Medicine Foundation

💊 Will Global Leaders Take Action on Antimicrobial Resistance? The clock is ticking. Antimicrobial resistance #AMR knows no borders, and no single country can tackle it alone. Today, during the 79th session of the UN General Assembly (UNGA 79), global leaders will gather in New York for the second-ever UN High-Level Meeting on AMR. This is a pivotal moment for countries to unite and address AMR's growing threat to global health, food security, and the 2030 Sustainable Development Goals. AVMA (American Veterinary Medical Association), CVMA, and FVE have long advocated for a coordinated global #OneHealth response to AMR. The latest version of the political declaration: https://buff.ly/3Nl1xit The AVMA, CVMA and FVE joint statements on Antimicrobial Resistance https://buff.ly/3N2bRLO United Nations

🌍 World AMR Awareness Week 2024 is here! At ICARS, we are honored to work alongside ministries, researchers, and global partners in Low- and Middle-Income Countries (#LMICs) to address the growing challenge of Antimicrobial Resistance (#AMR).   🛡️ This year’s theme, “Educate. Advocate. Act now,” highlights the importance of raising awareness, fostering collaboration, and taking meaningful steps to address AMR across the #OneHealth spectrum.   🌱 ICARS collaborates with over 70 research and ministry partners across 20+ LMICs to co-develop solutions that are context-specific, cost-effective, and scalable, supporting countries in implementing their AMR National Action Plans.   💡 As we reflect on our journey, we are deeply inspired by the knowledge, dedication, and commitment of our partners, who drive this vital work forward.   📷 Today, we are sharing a glimpse of some of our team members—a few of the 40+ colleagues from over 20 nationalities who contribute their diverse perspectives and expertise to our efforts.   🤝 Let’s use this week to educate, advocate, and act. Every contribution matters in the global response to AMR.   Meet the ICARS team ➡️ https://bit.ly/3APh4El   #WAAW2024 #GoingBlueForAMR #GlobalHealth #AntimicrobialResistance #WAAW World Health Organization FAO UN Environment Programme World Organisation for Animal Health